
Following the announcement that Dr. Moncef Slaoui will lead the Trump Administration's "Operation Warp Speed" initiative, BIO’s President and CEO, Jim Greenwood, issued the following statement:
“Dr. Moncef Slaoui is an excellent choice to lead the President’s Operation Warp Speed initiative. Over his long career, he has demonstrated a strong commitment to public health, innovation and a public-private partnership that are vital to building the collaborations we need to bring new therapeutics, diagnostics and vaccines to the American people. Dr. Slaoui has always stood for scientific excellence, and the biotechnology industry stands ready to work with him as we begin this new effort in the race to eradicate the pandemic.”
###
Discover More
The Biotechnology Innovation Organization today announced the opening of nominations for two awards to honor significant leaders driving cutting-edge, sustainable breakthroughs in the fields of agriculture and the environment.
The George…
The Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Executive Committee directors for the 2022-2023 term.
BIO’s Board elections took place Monday, June 13 during the 2022 BIO International Convention…
The third annual report that examines diversity, equity, and inclusion (DEI) in the biotechnology industry launched today at the 2022 BIO International Convention. The report, “Measuring Diversity in the Biotech Industry: Tracking Progress in Small…
Explore BIO
BIO DOUBLE HELIX SPONSORS







BIO HELIX SPONSORS




1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2022 All Rights Reserved